Cytoseek

CytoSeek is a specialized biotechnology company focused on the development and delivery of next-generation cell therapies. The company is particularly oriented towards advancements in cancer treatment methods, specifically targeting solid tumors. Through their innovative Artificial Membrane-Binding Protein (AMBP) technology, CytoSeek aims to enhance the efficiency, safety, and manufacturability of cell therapies by enabling precision membrane engineering. This fast, flexible, and focused technology allows the company to work with virtually all cell types, thus broadening their approach and uses in the field of medical therapeutics.

CytoSeek was formed to commercialize the groundbreaking work of Professor Adam Perriman and his team at the University of Bristol. Since its inception, the company has concentrated on enhancing cell therapies to combat solid tumors through their patented AMBP technology. This technology not only binds to various cell types but also allows the addition of new functionalities such as 'arming' cells with stimulating proteins, 'aiming' cells and vectors to specific cell types, and 'amplifying' cell numbers through proliferation. Currently in the proof-of-principle stage, CytoSeek is actively developing multiple AMBPs combined with various immune cell types to drive transformative cell therapies.

As a company driving innovation in cancer treatment, CytoSeek represents a promising contender in the global fight against cancer. They actively seek partnerships to further co-develop their technology, demonstrating their commitment to collaboration in the advancement of medical science. The company's innovative approach to developing transformative cell therapies offers potential partners and stakeholders an exciting opportunity to be part of life-changing technology that could significantly improve cancer treatment methods. Furthermore, their specific focus on addressing the challenges of solid tumors underscores the company's dedication to countering complex and pressing health issues.

Connect